Clinical trial on the efficacy of an intervention package to improve adherence to treatment for systolic blood pressure (BP) reduction in primary care patients with poorly controlled or uncontrolled BP

A randomised controlled trial on the efficacy of a multifactorial intervention to improve adherence to treatment for systolic blood pressure (BP) reduction in primary care patients with poorly controlled or uncontrolled BP

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN21229328

Enrollment

309

Registered

2010-07-27

Start date

2010-10-15

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-optimally controlled hypertension Circulatory System Essential (primary) hypertension

Interventions

Patients in the intervention group will attend of 3 sessions consisting of a 30 minute semi-structured motivational interview and a 15-minute health education programme combined with simplifying dosin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Current inclusion criteria as of 16/01/2013: 1. Patients between 18 and 80 years of age 2. Non controlled BP according to European Societies of Hypertension and Cardiology (ESH/ESC) guidelines (i.e. BP less than 140/90 mmHg or less than 130/80 mmHg in diabetic or renal failure patients) Previous inclusion criteria until 16/01/2013: 1. Patients between 18 and 80 years of age 2. Non controlled BP according to European Societies of Hypertension and Cardiology (ESH/ESC) guidelines (i.e. BP less than 140/90 mmHg or less than 130/80 mmHg in diabetic or renal failure patients) 3. Adherence below 80% to AHT by Hayness-Sacket Test

Exclusion criteria

Exclusion criteria: 1. Non-essential hypertensive patients 2. Haemodialysis patients 3. Institutionalised patients

Design outcomes

Primary

Measure	Time frame
Change in systolic BP at 12 months	—

Secondary

Measure	Time frame
1. Change in diastolic BP 2. Proportion of participants with adequate BP control at 12 months 3. Total direct cost	—

Countries

Spain

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 7, 2026